Cargando…
Methyl-CpG-binding protein 2 drives the Furin/TGF-β1/Smad axis to promote epithelial–mesenchymal transition in pancreatic cancer cells
Methyl-CpG-binding protein 2 (MeCP2) has been characterized as an oncogene in several types of cancer. However, its precise role in pancreatic ductal adenocarcinoma (PDAC) remains unclear. Hence, this study aimed to evaluate the potential role of MeCP2 in pancreatic cancer progression. We found that...
Autores principales: | Wang, Huizhi, Li, Jie, He, Junbo, Liu, Yawen, Feng, Wen, Zhou, Hailang, Zhou, Meng, Wei, Hong, Lu, Ying, Peng, Wanxin, Du, Fengyi, Gong, Aihua, Xu, Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7450052/ https://www.ncbi.nlm.nih.gov/pubmed/32848128 http://dx.doi.org/10.1038/s41389-020-00258-y |
Ejemplares similares
-
Methyl-CpG-binding domain 3 inhibits epithelial–mesenchymal transition in pancreatic cancer cells via TGF-β/Smad signalling
por: Xu, Min, et al.
Publicado: (2017) -
PRMT5 promotes epithelial‐mesenchymal transition via EGFR‐β‐catenin axis in pancreatic cancer cells
por: Ge, Lu, et al.
Publicado: (2019) -
MeCP2 suppresses LIN28A expression via binding to its methylated-CpG islands in pancreatic cancer cells
por: Xu, Min, et al.
Publicado: (2016) -
Preservation of methylated CpG dinucleotides in human CpG islands
por: Panchin, Alexander Y., et al.
Publicado: (2016) -
Suppressive CpG
por: Van Epps, Heather L.
Publicado: (2005)